EPA’s Supplemental “Transparency in Regulatory Science” Rule Likely to Restrict the Use of Scientific Studies in Determining Pivotal Environmental Actions
The U.S. Environmental Protection Agency (EPA) is planning to publish a supplemental proposed rule that would expand the applicability of a preexisting proposed rule from 2018 impacting how environmental regulations come about.
The
supplemental proposal would require underlying data in scientific studies
used in the promulgation of significant regulatory actions be
publicly available—underlying data that’s often confidential, proprietary,
and may contain private personal information subject to confidentiality
agreements.
As reported by the New York Times, this rulemaking action would
supplement the April 2018 proposed rule entitled “Strengthening Transparency in
Regulatory Science,” (83 FR 18768) in
response to public comments. The EPA’s stated intent for the rule was to
ensure data underlying scientific studies that are pivotal to deciding
agency action are “publicly available in a manner sufficient for
independent validation.” While the April 2018 rule proposal stated that it
would be applicable only to dose-response data and models, the supplemental
proposal indicates that this rule on the availability of underlying data would
be applicable to all data and models. On November 13, 2019, the House
Committee on Science, Space, and Technology held a hearing on the proposed rule.
This
proposed rule has been subject to significant criticism, including
from the Union of Concerned Scientists, as
some argue that the rule would make it more difficult to
enact new environmental regulations because the studies underlying
those proposed actions rely on personal health information and proprietary
data gathered under confidentiality agreements.
Furthermore,
even if the studies are submitted to EPA for consideration along with the
proposed regulatory action, EPA and/or those conducting the studies would have
to spend significant resources to redact the private information in the data in
order to qualify for consideration by the agency. The supplemental
proposed rule being debated now, therefore, has the potential to significantly
limit the admissibility and applicability of legitimate scientific studies in
the promulgation of proposed environmental regulatory action.
In
response to these concerns about the limitation on the use of certain data and
models in EPA’s decision-making process, the proposed supplemental rule states that
the EPA is considering two alternatives to the proposed approach. These two
alternatives include a weighing option and a tiered data access option.
The weighing option would essentially enable the EPA to give consideration
to data and models where the underlying information are not publicly available,
but would allow the agency to assign a lower weight to the study’s evidence,
findings, and conclusion. The tiered data access option would provide
for tiered access to data and models that have confidential information, such
that independent validation of these data and models may be accomplished in the
restricted context by a person or persons authorized to have access to the
restricted data and models. Under this alternative approach, the EPA argues,
“the more sensitive the data and models, the more restricted the access would
be.”
It’s
likely that this proposed rulemaking action will be subject to further
criticism upon the publication of the rule for public comment, as the
alternatives proposed raise questions on the practicality and feasibility of
utilizing these measures to circumvent the consideration of pivotal scientific
studies. While the intended goal of this action is to increase transparency,
its overarching effect would likely be a reduced consideration of
legitimate scientific studies in determining the course of environmental
regulation in the United States moving forward.
EPA’s Supplemental “Transparency in Regulatory Science” Rule Likely to Restrict the Use of Scientific Studies in Determining Pivotal Environmental Actions
The U.S. Environmental Protection Agency (EPA) is planning to publish a supplemental proposed rule that would expand the applicability of a preexisting proposed rule from 2018 impacting how environmental regulations come about.
The supplemental proposal would require underlying data in scientific studies used in the promulgation of significant regulatory actions be publicly available—underlying data that’s often confidential, proprietary, and may contain private personal information subject to confidentiality agreements.
As reported by the New York Times, this rulemaking action would supplement the April 2018 proposed rule entitled “Strengthening Transparency in Regulatory Science,” (83 FR 18768) in response to public comments. The EPA’s stated intent for the rule was to ensure data underlying scientific studies that are pivotal to deciding agency action are “publicly available in a manner sufficient for independent validation.” While the April 2018 rule proposal stated that it would be applicable only to dose-response data and models, the supplemental proposal indicates that this rule on the availability of underlying data would be applicable to all data and models. On November 13, 2019, the House Committee on Science, Space, and Technology held a hearing on the proposed rule.
This proposed rule has been subject to significant criticism, including from the Union of Concerned Scientists, as some argue that the rule would make it more difficult to enact new environmental regulations because the studies underlying those proposed actions rely on personal health information and proprietary data gathered under confidentiality agreements.
Furthermore, even if the studies are submitted to EPA for consideration along with the proposed regulatory action, EPA and/or those conducting the studies would have to spend significant resources to redact the private information in the data in order to qualify for consideration by the agency. The supplemental proposed rule being debated now, therefore, has the potential to significantly limit the admissibility and applicability of legitimate scientific studies in the promulgation of proposed environmental regulatory action.
In response to these concerns about the limitation on the use of certain data and models in EPA’s decision-making process, the proposed supplemental rule states that the EPA is considering two alternatives to the proposed approach. These two alternatives include a weighing option and a tiered data access option. The weighing option would essentially enable the EPA to give consideration to data and models where the underlying information are not publicly available, but would allow the agency to assign a lower weight to the study’s evidence, findings, and conclusion. The tiered data access option would provide for tiered access to data and models that have confidential information, such that independent validation of these data and models may be accomplished in the restricted context by a person or persons authorized to have access to the restricted data and models. Under this alternative approach, the EPA argues, “the more sensitive the data and models, the more restricted the access would be.”
It’s likely that this proposed rulemaking action will be subject to further criticism upon the publication of the rule for public comment, as the alternatives proposed raise questions on the practicality and feasibility of utilizing these measures to circumvent the consideration of pivotal scientific studies. While the intended goal of this action is to increase transparency, its overarching effect would likely be a reduced consideration of legitimate scientific studies in determining the course of environmental regulation in the United States moving forward.
Jacob Kronish
You might also like
New York Bans Products Containing 1,4-Dioxane Effective January 1, 2022
Colorless Haze? Carcinogenic Gas Found at Monitoring Sites in 16 Cities
EPA Denies New York’s Good Neighbor Request
We Need to Talk … It’s Not Me, It’s You: EPA Accuses California of Worsening Environmental Issues
Next ArticleEPA Announces Draft Risk Evaluation for N-Methylpyrrolidon (NMP)